300463 迈克生物
交易中 06-04 09:44:21
资讯
新帖
简况
迈克生物：智慧化实验室以患者为中心
证券之星 · 44分钟前
迈克生物：智慧化实验室以患者为中心
迈克生物：国内构建三级经销渠道
证券之星 · 54分钟前
迈克生物：国内构建三级经销渠道
迈克生物：公司对该业务的中长期发展目标保持坚定信心
证券之星 · 06-02 20:51
迈克生物：公司对该业务的中长期发展目标保持坚定信心
股市必读：迈克生物（300463）6月1日董秘有最新回复
证券之星 · 06-02 02:17
股市必读：迈克生物（300463）6月1日董秘有最新回复
迈克生物：公司流水线轨道传输及机械臂不属于物理AI
证券之星 · 06-01 20:51
迈克生物：公司流水线轨道传输及机械臂不属于物理AI
迈克生物：不存在您提及的复苏落后、核心骨干流失、持续亏损等问题
证券之星 · 06-01 16:03
迈克生物：不存在您提及的复苏落后、核心骨干流失、持续亏损等问题
迈克生物：公司自成立以来始终专注于体外诊断产品的研发、生产、销售和服务
证券之星 · 06-01 15:38
迈克生物：公司自成立以来始终专注于体外诊断产品的研发、生产、销售和服务
迈克生物：公司流水线轨道传输及机械臂不属于具身智能机器人
证券之星 · 05-29
迈克生物：公司流水线轨道传输及机械臂不属于具身智能机器人
迈克生物：截止26年一季度末累计签单70家
证券之星 · 05-27
迈克生物：截止26年一季度末累计签单70家
迈克生物：公司不存在引入四川或其他地方国资控股、接盘股权的意向或计划
证券之星 · 05-27
迈克生物：公司不存在引入四川或其他地方国资控股、接盘股权的意向或计划
迈克生物：2025年海外销售收入2.23亿元
证券之星 · 05-22
迈克生物：2025年海外销售收入2.23亿元
迈克生物：积极评估智慧化实验室推广与落地、海外市场拓展、上游原材料等领域合作机会
证券之星 · 05-22
迈克生物：积极评估智慧化实验室推广与落地、海外市场拓展、上游原材料等领域合作机会
迈克生物：公司自成立以来始终专注于体外诊断产品的研发、生产、销售和服务
证券之星 · 05-22
迈克生物：公司自成立以来始终专注于体外诊断产品的研发、生产、销售和服务
迈克生物（300463）披露2025年年度股东会决议公告，5月21日股价下跌3.14%
证券之星 · 05-21
迈克生物（300463）披露2025年年度股东会决议公告，5月21日股价下跌3.14%
迈克生物（300463）披露2025年年度股东会召开提示性公告，5月15日股价下跌1.62%
证券之星 · 05-15
迈克生物（300463）披露2025年年度股东会召开提示性公告，5月15日股价下跌1.62%
迈克生物：已形成从试剂到仪器、从单机到流水线的系列化、系统化产品矩阵
证券之星 · 05-08
迈克生物：已形成从试剂到仪器、从单机到流水线的系列化、系统化产品矩阵
每周股票复盘：迈克生物（300463）2026年一季报净利降62.53%
证券之星 · 05-03
每周股票复盘：迈克生物（300463）2026年一季报净利降62.53%
迈克生物（300463）2026年一季报简析：净利润同比下降62.53%，公司应收账款体量较大
证券之星 · 04-30
迈克生物（300463）2026年一季报简析：净利润同比下降62.53%，公司应收账款体量较大
迈克生物(300463)3月31日股东户数3.6万户，较上期增加12.11%
证券之星 · 04-29
迈克生物(300463)3月31日股东户数3.6万户，较上期增加12.11%
图解迈克生物一季报：第一季度单季净利润同比下降62.53%
证券之星 · 04-29
图解迈克生物一季报：第一季度单季净利润同比下降62.53%
加载更多
公司概况
公司名称：
迈克生物股份有限公司
所属行业：
医药制造业
上市日期：
2015-05-28
主营业务：
迈克生物股份有限公司的主营业务是体外诊断产品的研发、生产、销售和服务。公司的主要产品是免疫、生化、分子诊断提取、分子诊断荧光PCR、血常规产品、凝血产品、血型产品、血气产品、尿液产品。
发行价格：
27.96
{"stockData":{"symbol":"300463","market":"SZ","secType":"STK","nameCN":"迈克生物","latestPrice":9.16,"timestamp":1780537461000,"preClose":9.24,"halted":0,"volume":727000,"delay":0,"changeRate":-0.0087,"floatShares":491000000,"shares":605000000,"eps":-0.0841,"marketStatus":"交易中","change":-0.08,"latestTime":"06-04 09:44:21","open":9.2,"high":9.27,"low":9.13,"amount":6705600,"amplitude":0.0152,"askPrice":9.17,"askSize":73,"bidPrice":9.16,"bidSize":69,"shortable":0,"etf":0,"ttmEps":-0.0841,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1780543800000},"marketStatusCode":2,"adr":0,"adjPreClose":9.24,"symbolType":"stock","openAndCloseTimeList":[[1780536600000,1780543800000],[1780549200000,1780556400000]],"highLimit":10.16,"lowLimit":8.32,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":604666624,"isCdr":false,"pbRate":0.89,"roa":"--","roe":"0.14%","epsLYR":-0.0593,"committee":0.513961,"marketValue":5539000000,"turnoverRate":0.0015,"status":1,"floatMarketCap":4502000000},"requestUrl":"/m/hq/s/300463","defaultTab":"news","newsList":[{"id":"2640013336","title":"迈克生物：智慧化实验室以患者为中心","url":"https://stock-news.laohu8.com/highlight/detail?id=2640013336","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640013336?lang=zh_cn&edition=full","pubTime":"2026-06-04 09:01","pubTimestamp":1780534885,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物06月03日在投资者关系平台上答复投资者关心的问题。对医疗机构和患者都是非常有利的。智慧化实验室以患者为中心，打造基于自动化、数智化的医学实验室全面解决方案，构建“检验数据工厂+智能决策中心”两大核心价值单元。凭借完善的技术平台与丰富的产品矩阵，迈克搭建起智慧化实验室的核心建设基础，成功实现“智慧检验-智慧管理-智慧运营”的全流程闭环管理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400005066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","300463","BK0046","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640380871","title":"迈克生物：国内构建三级经销渠道","url":"https://stock-news.laohu8.com/highlight/detail?id=2640380871","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640380871?lang=zh_cn&edition=full","pubTime":"2026-06-04 08:51","pubTimestamp":1780534273,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物06月03日在投资者关系平台上答复投资者关心的问题。投资者提问：公司目前在国内构建了三级经销渠道，国内经销商达到61家，产品覆盖7800家医疗机构，二级和三级医院覆盖率达到26%和58%，以上这些是全国性的覆盖率还是包括了海外业务；海外业务聚焦“12+1”重点国家和地区是否主要为欧美市场迈克生物回复：尊敬的投资，您好！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400004946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0012","BK0028","BK0046","300463"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640994392","title":"迈克生物：公司对该业务的中长期发展目标保持坚定信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2640994392","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640994392?lang=zh_cn&edition=full","pubTime":"2026-06-02 20:51","pubTimestamp":1780404671,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物06月01日在投资者关系平台上答复投资者关心的问题。目前，国内能够提供完整智慧化实验室解决方案的厂家极为有限，公司对该业务的中长期发展目标保持坚定信心。公司将按照业务整体发展目标努力推进全年目标达成，相关签单、交付等具体经营数据，请关注公司后续定期报告及官方合规披露内容。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200044695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","BK0028","300463","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640969344","title":"股市必读：迈克生物（300463）6月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640969344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640969344?lang=zh_cn&edition=full","pubTime":"2026-06-02 02:17","pubTimestamp":1780337830,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，迈克生物报收于9.63元，上涨1.9%，换手率1.06%，成交量5.21万手，成交额4972.31万元。董秘最新回复投资者： 在行业回暖、牛市持续一年多的背景下，贵司成为头部 IVD 中唯一年度亏损、股价大幅跑输板块的公司。目前暂无增资扩股意向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200001769.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0012","BK0046","300463"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640954549","title":"迈克生物：公司流水线轨道传输及机械臂不属于物理AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2640954549","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640954549?lang=zh_cn&edition=full","pubTime":"2026-06-01 20:51","pubTimestamp":1780318287,"startTime":"0","endTime":"0","summary":"公司流水线轨道传输及机械臂主要用于实验室内部样本传输和处理，不属于物理AI，也不属于具身智能机器人，均属于医学实验室自动化、智能化的常规技术应用，例如全自动样本处理系统LABAS MAX搭载了AI视觉识别技术，显著提升了检测效率和准确性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100038026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300463","BK0046","BK0012","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640343509","title":"迈克生物：不存在您提及的复苏落后、核心骨干流失、持续亏损等问题","url":"https://stock-news.laohu8.com/highlight/detail?id=2640343509","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640343509?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:03","pubTimestamp":1780300987,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物06月01日在投资者关系平台上答复投资者关心的问题。但是贵司研发新人化、核心骨干流失、内耗严重，智慧实验室落地不及预期，海外布局低端化，集采冲击下业绩持续亏损，五年股价暴跌 85%。公司在过往互动易回复中已就战略方向、业务进展及行业判断进行了多轮说明，不存在您提及的复苏落后、核心骨干流失、持续亏损等问题。感谢您的持续关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100020925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0046","300463","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640931848","title":"迈克生物：公司自成立以来始终专注于体外诊断产品的研发、生产、销售和服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2640931848","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640931848?lang=zh_cn&edition=full","pubTime":"2026-06-01 15:38","pubTimestamp":1780299491,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物06月01日在投资者关系平台上答复投资者关心的问题。公司自成立以来始终专注于体外诊断产品的研发、生产、销售和服务。目前暂无增资扩股意向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100017424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0012","300463","BK0046","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639620540","title":"迈克生物：公司流水线轨道传输及机械臂不属于具身智能机器人","url":"https://stock-news.laohu8.com/highlight/detail?id=2639620540","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639620540?lang=zh_cn&edition=full","pubTime":"2026-05-29 20:52","pubTimestamp":1780059141,"startTime":"0","endTime":"0","summary":"公司流水线轨道传输及机械臂主要用于实验室内部样本传输和处理，不属于具身智能机器人，也不归类为医疗服务机器人，均属于医学实验室自动化、智能化的常规技术应用，例如全自动样本处理系统LABAS MAX搭载了AI视觉识别技术，显著提升了检测效率和准确性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900043523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0046","300463","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638889776","title":"迈克生物：截止26年一季度末累计签单70家","url":"https://stock-news.laohu8.com/highlight/detail?id=2638889776","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638889776?lang=zh_cn&edition=full","pubTime":"2026-05-27 20:48","pubTimestamp":1779886108,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物05月26日在投资者关系平台上答复投资者关心的问题。首先，关于智慧化实验室解决方案的推进，公司制定了年度销售预算指标及中长期市场目标，其中截止26年一季度末累计签单目标超过100家，实际执行结果为累计签单70家，其中一季度新增签单约14家。尽管如此，在当前的行业环境下，一季度新增14家、累计近70家的成绩仍属稳健表现。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700043354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0012","300463","BK0046","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638457352","title":"迈克生物：公司不存在引入四川或其他地方国资控股、接盘股权的意向或计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2638457352","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638457352?lang=zh_cn&edition=full","pubTime":"2026-05-27 11:36","pubTimestamp":1779853014,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物(300463)05月26日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘你好，请问公司是否存在引入四川或其他地方国资控股、接盘股权的意向？高管持续抛售是否就是为国资入主铺路？后续有无相关股权变更、国资战略入股的规划？请正面如实披露，切勿以无应披露事项敷衍投资者。迈克生物回复：答：尊敬的投资者，您好！公司不存在引入四川或其他地方国资控股、接盘股权的意向或计划，亦无相关股权变更、国资战略入股的规划。感谢您的关注与支持！以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700019965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","300463","BK0012","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637128753","title":"迈克生物：2025年海外销售收入2.23亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637128753","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637128753?lang=zh_cn&edition=full","pubTime":"2026-05-22 20:52","pubTimestamp":1779454359,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物05月21日在投资者关系平台上答复投资者关心的问题。公司已将在多款产品应用AI技术，如尿液、血球、病理等图像识别，以及全自动样本处理系统LABAS MAX的AI视觉识别，提升检测效率。在海外业务板块，公司2025年海外销售收入2.23亿元，同比增长37.69%，海外收入占公司营业收入比例约10%。以上内容为证券之星据公开信息整理，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200042482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300463","BK0012","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637627033","title":"迈克生物：积极评估智慧化实验室推广与落地、海外市场拓展、上游原材料等领域合作机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2637627033","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637627033?lang=zh_cn&edition=full","pubTime":"2026-05-22 11:34","pubTimestamp":1779420853,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物(300463)05月21日在投资者关系平台上答复投资者关心的问题。投资者提问：今年马来西亚年会上你们董事长说要大胆寻找合作伙伴，请问你们的合作伙伴找到了吗？具体你们要找那个方面的合作伙伴？近期有没有目标与方向？迈克生物回复：答：尊敬的投资者，您好！公司根据目前的战略发展，积极评估在智慧化实验室推广与落地、海外市场拓展、上游原材料等领域的潜在合作机会。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200019229.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300463","BK0028","BK0239","BK0012","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637620643","title":"迈克生物：公司自成立以来始终专注于体外诊断产品的研发、生产、销售和服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2637620643","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637620643?lang=zh_cn&edition=full","pubTime":"2026-05-22 11:34","pubTimestamp":1779420853,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物05月21日在投资者关系平台上答复投资者关心的问题。变更证券简称属于重大事项，公司会综合考虑战略定位及投资者意见。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200019231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300463","BK0239","BK0046","BK0028","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637238196","title":"迈克生物（300463）披露2025年年度股东会决议公告，5月21日股价下跌3.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637238196","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637238196?lang=zh_cn&edition=full","pubTime":"2026-05-21 17:48","pubTimestamp":1779356922,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，迈克生物报收于9.88元，较前一交易日下跌3.14%，最新总市值为59.74亿元。该股当日开盘10.2元，最高10.27元，最低9.86元，成交额达1.28亿元，换手率为2.59%。迈克生物于近日披露《2025年年度股东会决议公告》。会议表决结果合法有效，出席股东代表股份占总股本40.3348%，中小投资者参与单独计票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100033133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0046","300463","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635170090","title":"迈克生物（300463）披露2025年年度股东会召开提示性公告，5月15日股价下跌1.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635170090","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635170090?lang=zh_cn&edition=full","pubTime":"2026-05-15 17:33","pubTimestamp":1778837630,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，迈克生物报收于10.34元，较前一交易日下跌1.62%，最新总市值为62.52亿元。该股当日开盘10.51元，最高10.58元，最低10.25元，成交额达9844.02万元，换手率为1.93%。近日，迈克生物股份有限公司发布《关于召开2025年年度股东会的提示性公告》。公告显示，公司定于2026年5月20日召开2025年年度股东会，会议采取现场投票与网络投票相结合方式。股权登记日为2026年5月13日。其中部分议案涉及关联股东回避表决，中小投资者表决将单独计票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500032740.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0012","BK0046","BK0028","300463"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633459239","title":"迈克生物：已形成从试剂到仪器、从单机到流水线的系列化、系统化产品矩阵","url":"https://stock-news.laohu8.com/highlight/detail?id=2633459239","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633459239?lang=zh_cn&edition=full","pubTime":"2026-05-08 20:52","pubTimestamp":1778244750,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物05月07日在投资者关系平台上答复投资者关心的问题。公司自主产品涵盖生化、免疫、血球、血凝、血型、尿液、分子等多个产品平台，已形成从试剂到仪器、从单机到流水线的系列化、系统化产品矩阵，可以覆盖医学实验室80%检测项目，为自动化流水线、智慧化实验室的构建提供了坚实的产品基础。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800041234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","300463","BK0012","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632701896","title":"每周股票复盘：迈克生物（300463）2026年一季报净利降62.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632701896","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632701896?lang=zh_cn&edition=full","pubTime":"2026-05-03 07:01","pubTimestamp":1777762877,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，迈克生物报收于10.49元，较上周的10.39元上涨0.96%。本周关注点来自业绩披露要点：迈克生物2026年一季报显示归母净利润同比下降62.53%。股本股东变化股东户数变动截至2026年3月31日，迈克生物股东户数为3.6万户，较2025年12月31日增加3,893户，增幅12.11%。迈克生物股份有限公司2025年度内部控制自我评价报告截至2025年12月31日，公司不存在财务报告和非财务报告内部控制重大缺陷，内部控制制度在所有重大方面保持有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001689.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300463","BK0012","BK0028","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631200455","title":"迈克生物（300463）2026年一季报简析：净利润同比下降62.53%，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2631200455","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631200455?lang=zh_cn&edition=full","pubTime":"2026-04-30 06:42","pubTimestamp":1777502569,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期迈克生物发布2026年一季报。截至本报告期末，公司营业总收入4.75亿元，同比下降6.86%，归母净利润898.61万元，同比下降62.53%。本报告期迈克生物公司应收账款体量较大，当期应收账款占最新年报营业总收入比达48.52%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000022695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300463"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631599737","title":"迈克生物(300463)3月31日股东户数3.6万户，较上期增加12.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631599737","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631599737?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:01","pubTimestamp":1777456908,"startTime":"0","endTime":"0","summary":"证券之星消息，近日迈克生物披露，截至2026年3月31日公司股东户数为3.6万户，较12月31日增加3893.0户，增幅为12.11%。在医疗器械行业个股中，迈克生物股东户数高于行业平均水平，截至3月31日，医疗器械行业平均股东户数为2.2万户。从股价来看，2025年12月31日至2026年3月31日，迈克生物区间跌幅为4.2%，在此期间股东户数增加3893.0户，增幅为12.11%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900056821.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300463","BK0028","BK0239","BK0012","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631531523","title":"图解迈克生物一季报：第一季度单季净利润同比下降62.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631531523","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631531523?lang=zh_cn&edition=full","pubTime":"2026-04-29 05:13","pubTimestamp":1777410804,"startTime":"0","endTime":"0","summary":"证券之星消息，迈克生物2026年一季报显示，一季度公司主营收入4.75亿元，同比下降6.86%；归母净利润898.61万元，同比下降62.53%；扣非净利润988.5万元，同比下降75.18%；负债率21.0%，投资收益20.81万元，财务费用989.78万元，毛利率57.74%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900011522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300463"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780537465431,"stockEarnings":[{"period":"1week","weight":-0.0222},{"period":"1month","weight":-0.1192},{"period":"3month","weight":-0.1794},{"period":"6month","weight":-0.1951},{"period":"1year","weight":-0.2281},{"period":"ytd","weight":-0.1743}],"compareEarnings":[{"period":"1week","weight":-0.0024},{"period":"1month","weight":-0.0069},{"period":"3month","weight":-0.006},{"period":"6month","weight":0.0464},{"period":"1year","weight":0.2148},{"period":"ytd","weight":0.029}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"迈克生物股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"36044人(较上一季度增加12.11%)","perCapita":"13635股","listingDate":"2015-05-28","address":"四川省成都市郫都区高新区百川路16号","registeredCapital":"60466万元","survey":" 迈克生物股份有限公司的主营业务是体外诊断产品的研发、生产、销售和服务。公司的主要产品是免疫、生化、分子诊断提取、分子诊断荧光PCR、血常规产品、凝血产品、血型产品、血气产品、尿液产品。","listedPrice":27.96},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迈克生物(300463)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迈克生物(300463)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迈克生物,300463,迈克生物股票,迈克生物股票老虎,迈克生物股票老虎国际,迈克生物行情,迈克生物股票行情,迈克生物股价,迈克生物股市,迈克生物股票价格,迈克生物股票交易,迈克生物股票购买,迈克生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迈克生物(300463)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迈克生物(300463)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}